Develops drugs for various diseases.
Dec 2025Revenue £32.7B/yrExpenses £24.7B/yr
No trend
Figures by year
Is GSK profitable?
Yes. In the 12 months to Dec 2025, revenue was £32.7B and expenses £24.7B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | £32.7B | £24.7B | £7.93B |
| Dec 2024 | £31.4B | £27.4B | £4.02B |
| Dec 2023 | £30.3B | £23.6B | £6.75B |
| Dec 2022 | £29.3B | £22.9B | £6.43B |
| Dec 2021 | £24.7B | £20.3B | £4.36B |
| Dec 2020 | £24.4B | £18.4B | £5.98B |
| Dec 2019 | £33.8B | £26.8B | £6.96B |
| Dec 2018 | £30.8B | £25.3B | £5.48B |
| Dec 2017 | £30.2B | £26.1B | £4.09B |
| Dec 2016 | £27.9B | £25.3B | £2.60B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.